About
Small Molecule Drug Discovery
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
1,304
By Phase
PHASE2: 4PHASE1: 4
By Status
COMPLETED: 4ACTIVE_NOT_RECRUITING: 2RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06628362Lead Sponsor
A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
PHASE2Active, not recruiting
360 participants
Started: Nov 21, 2024 · Completed: Nov 30, 2026
NCT06525935Lead Sponsor
A Study of CT-388 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
PHASE2Active, not recruiting
450 participants
Started: Aug 16, 2024 · Completed: Feb 21, 2026
NCT06062069Lead Sponsor
A Study of CT-868 in Type 1 Diabetes Mellitus
PHASE2Completed
111 participants
Started: Oct 19, 2023 · Completed: Jul 9, 2025
NCT05814107Collaborator
Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus
PHASE1Recruiting
94 participants
Started: May 9, 2023 · Completed: Oct 31, 2025
NCT05794581Lead Sponsor
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
PHASE1Completed
32 participants
Started: Mar 21, 2023 · Completed: Apr 6, 2024
Locations (1)
Headquarters
Berkeley, CA, United States
Map
Loading map...